Criticality: A New Concept of Severity of Illness for Hospitalized Children

Eduardo A Trujillo Rivera1, Anita K Patel2, James M Chamberlain3

  • 1George Washington University School of Medicine and Health Sciences, Washington, DC.

Insights

A new Criticality Index accurately measures pediatric inpatient severity using physiology and therapy data. This tool helps predict future care needs for hospitalized children.

Area of Science:

  • Pediatric critical care medicine
  • Health informatics
  • Machine learning in healthcare

Background:

  • Assessing pediatric inpatient severity is complex.
  • Existing measures may not fully capture nuances of care intensity.
  • A novel approach is needed to quantify pediatric patient acuity.

Purpose of the Study:

  • To validate the conceptual framework of "criticality" as a pediatric inpatient severity measure.
  • To operationalize criticality using physiology, therapy, and therapeutic intensity.
  • To calibrate the measure against intensive care unit (ICU) care.

Main Methods:

  • Deep neural network analysis of a national pediatric database (Health Facts).
  • Utilized laboratory tests, vital signs, and medication data.
  • Modeled care intensity (ICU vs. routine care) every 6 hours.

Main Results:

  • The Criticality Index demonstrated excellent separation of severity hierarchies.
  • Achieved high performance metrics: AUC 0.95, sensitivity 0.817, specificity 0.892.
  • 88% of Criticality Indices correctly reflected higher intensity care locations.

Conclusions:

  • The Criticality Index quantifies pediatric severity using physiology, therapy, and care intensity.
  • This novel conceptual model is applicable to clinical investigations.
  • The index can aid in predicting future healthcare needs for hospitalized children.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
145
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
166
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
135
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
108
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
362